Gastrointestinal Effects Nausea, diarrhea, and constipation represent the most common side effects during Retatrutide use
Leveraging the University of California Health Data Warehouse enabled a realworld analysis of 6,871 patients with primary colon cancer and rigorous adjustment strategies to probe whether GLP1 RA exposure relates to fiveyear mortality. At the end of the study, researchers found that participants with colon cancer taking GLP-1 medications had a 15.5% mortality risk within 5 years, compared to 37.1% in participants not taking the drugs
This creates a cycle where you must stay on the drug indefinitely to maintain your weight
We've written more about where retatrutide stands in the UK and what the trial results actually show
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
At West Broward Eyecare Associates, we use the latest 2024 and 2025 clinical data to help you protect your retinal health through evidence-based nutritional interventions